Dr. Dandan Tian, Henan Provincial People’s Hospital, China
Dr. Dandan Tian is a medical professional at Henan Provincial People’s Hospital in China. With a focus on clinical practice, her expertise spans a variety of medical specialties, particularly in patient care and hospital management. Dr. Tian has made significant contributions to advancing healthcare in the region through her dedication to improving medical services and patient outcomes. She is well-regarded for her professional approach, collaboration with medical teams, and commitment to providing high-quality healthcare. Dr. Tian’s work has also involved research and development aimed at enhancing medical practices and addressing regional healthcare challenges.
Author Profile
Scopus Profile
EARLY ACADEMIC PURSUITS:
Dr. Dandan Tian’s academic journey laid a solid foundation for her distinguished career in hypertension prevention and treatment. After completing her formal medical education, she focused her studies on cardiovascular diseases, particularly hypertension, which has remained a central theme throughout her career. Her commitment to medical research, along with her clinical training, enabled her to understand the complexities of hypertension, and she quickly became passionate about improving treatment protocols and preventative care measures. Early on, her academic curiosity and dedication positioned her to contribute significantly to the growing body of knowledge in her field.
PROFESSIONAL ENDEAVORS:
Dr. Tian currently serves as the Attending Physician in the Hypertension Department of Henan Provincial People’s Hospital. This prestigious role allows her to apply her expertise in diagnosing and treating hypertension while maintaining a hands-on approach with patient care. Beyond her clinical responsibilities, Dr. Tian has taken on significant leadership roles, including Secretary of the Hypertension Prevention and Treatment Center of Henan Province and Secretary of the Hypertension Targeted Center Alliance. Her professional endeavors emphasize collaboration and innovation, as she continues to be a key player in hypertension care across the region.
CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:
Dr. Tian’s research focus has been on advancing hypertension prevention, treatment, and management through evidence-based practices. She has made substantial contributions to the field by leading one provincial-level research project and participating in multiple national-level research efforts. These research projects aim to enhance the clinical understanding of hypertension, explore new treatment methods, and implement effective prevention strategies. Her involvement in ministerial and provincial-level research further highlights her commitment to improving public health and addressing hypertension on a broader scale.
IMPACT AND INFLUENCE:
Dr. Tian’s impact extends beyond her clinical and research work. Her leadership in the Hypertension Prevention and Treatment Center of Henan Province and her membership in key medical societies, including the Henan Microcirculation Society, have solidified her influence in the medical community. Additionally, she plays a vital role in shaping healthcare policy and practice, particularly regarding hypertension management and prevention. Dr. Tian was recognized as an exemplary individual in disease prevention and control work by the province in 2021, reflecting the widespread acknowledgment of her contributions to public health.
ACADEMIC CITES AND RECOGNITION:
Dr. Tian’s research has garnered significant academic recognition, with citations from peers and professionals in the field of hypertension and cardiovascular health. Her work on hypertension prevention and treatment protocols has been widely cited, contributing to the academic discourse on hypertension management both within China and internationally. This recognition serves as a testament to the relevance and impact of her research in improving hypertension care practices.
LEGACY AND FUTURE CONTRIBUTIONS:
Dr. Tian’s legacy is shaped by her pioneering work in hypertension prevention and her dedication to improving patient outcomes. Her research and clinical expertise continue to inspire future generations of healthcare professionals and researchers. Moving forward, Dr. Tian’s contributions are expected to pave the way for further advancements in hypertension management, particularly with her ongoing leadership in various professional committees and research projects. She is committed to continuing her work in hypertension treatment and prevention, and her future contributions are likely to have an enduring impact on the field.
CONCLUSION:
Dr. Dandan Tian’s career reflects a deep commitment to both the clinical and academic sides of hypertension management. Her early academic pursuits, professional endeavors, and continued contributions to research have established her as a leader in the field. Through her work, she has influenced both healthcare policy and patient care practices. With a lasting impact on hypertension prevention, Dr. Tian is poised to continue making significant contributions to the field, solidifying her place as a leading figure in cardiovascular health.
TOP NOTABLE PUBLICATIONS
Article: Effects of obesity on aging brain and cognitive decline: A cohort study from the UK Biobank
Authors: Li, P., Zhu, X., Huang, C., Su, J., Tian, D.
Journal: IBRO Neuroscience Reports
Year: 2025
Article: Joint Exposure to Ambient Air Pollutants, Genetic Risk, and Ischemic Stroke: A Prospective Analysis in UK Biobank
Authors: Li, P., Wang, Y., Tian, D., Su, J., Wang, M.
Journal: Stroke
Year: 2024
Article: Analysis of clinical and biochemical characteristics and left ventricular hypertrophy in patients with indeterminate saline infusion test results
Authors: Qu, H., Zhao, J., Wang, L., Hao, Y., Liu, M.
Journal: Frontiers in Endocrinology
Year: 2024
Article: Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study
Authors: Tian, D., Xu, Y., Wang, Y., Li, P., Li, X.
Journal: Frontiers in Cardiovascular Medicine
Year: 2024
Article: Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension
Authors: Xu, F., Shen, L., Yang, Y., Cao, X., Huang, G.
Journal: Diabetes, Metabolic Syndrome and Obesity
Year: 2023
Article: Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers
Authors: Xu, F., Tian, D., Shi, X., Sun, K., Chen, Y.
Journal: Pathology and Oncology Research
Year: 2021
Article: Highly sensitive and selective photoelectrochemical sensor for mercury(II) detection based on efficient Bi2MoO6 photoanode decorated with CuS
Authors: Zhang, X., Li, M., He, L., Zhang, J., Liu, M.
Journal: Journal of Alloys and Compounds
Year: 2021
Article: ANGPTL8/betatrophin improves glucose tolerance in older mice and metabolomic analysis reveals its role in insulin resistance in HepG2 cells
Authors: Xu, F., Wang, N., Li, G., Tian, D., Shi, X.
Journal: Diabetes, Metabolic Syndrome and Obesity
Year: 2021
Article: Modeling analysis of the relationship between atherosclerosis and related inflammatory factors
Authors: Li, H., Zhang, P., Yuan, S., Tian, D., Liu, M.
Journal: Saudi Journal of Biological Sciences
Year: 2017